This inventor holds 3 USPTO granted patents and 5 published patent applications. Top assignees: The Cleveland Clinic Foundation, Other. Active years: 2017-2022.
Location History:
- Cleveland, OH (US) (2017)
- Solon, OH (US) (2019 - 2022)
Company Filing History:
2 out of 1,071 
1 out of 834,411 Years Active: 2017-2022
Title: Caini Liu: Innovator in IL-17A Related Treatments
Introduction
Caini Liu is a notable inventor based in Solon, OH (US). He has made significant contributions to the field of medical research, particularly in the treatment of IL-17A related diseases. With a total of 3 patents, Liu's work has the potential to impact many lives.
Latest Patents
Caini Liu's latest patents include innovative approaches to treating IL-17A related diseases. One of his patents focuses on SBE aptamers for treating these conditions. This invention provides compositions, systems, kits, and methods that utilize an SBE nucleic acid sequence to bind a SEFIR domain of an ACT1 protein. Another significant patent involves Flavonoid IL-17A inhibitors, which describes compounds that can be used in methods for the prevention or treatment of IL-17A-mediated diseases in subjects.
Career Highlights
Throughout his career, Caini Liu has worked with prestigious organizations, including the Cleveland Clinic Foundation. His research has been pivotal in advancing the understanding and treatment of IL-17A related conditions.
Collaborations
Caini Liu has collaborated with notable colleagues such as Xiaoxia Li and Liang Zhu. Their combined expertise has contributed to the success of Liu's innovative projects.
Conclusion
Caini Liu's work exemplifies the spirit of innovation in medical research. His patents and collaborations highlight his commitment to improving treatment options for IL-17A related diseases.